Industry NewsPharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s diseases
Product NewsPharmaKure and Universiti Teknologi MARA (UiTM) announce partnership to advance research in Alzheimer’s disease diagnosis
Industry NewsDr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023
Industry NewsPharmaKure announces study success for novel blood test to identify biomarkers in patients with Alzheimer’s disease